Canada markets closed

Aurinia Pharmaceuticals Inc. (AUPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.9900+0.1800 (+3.74%)
At close: 04:00PM EDT
5.0100 +0.02 (+0.40%)
After hours: 06:39PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 695.61M
Enterprise Value 442.73M
Trailing P/E N/A
Forward P/E 121.95
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.93
Price/Book (mrq)1.84
Enterprise Value/Revenue 2.52
Enterprise Value/EBITDA -7.02

Trading Information

Stock Price History

Beta (5Y Monthly) 1.38
52-Week Change 3-55.09%
S&P500 52-Week Change 321.23%
52 Week High 312.4300
52 Week Low 34.7100
50-Day Moving Average 35.6508
200-Day Moving Average 38.0479

Share Statistics

Avg Vol (3 month) 32.12M
Avg Vol (10 day) 31.3M
Shares Outstanding 5144.62M
Implied Shares Outstanding 6145.78M
Float 8131.74M
% Held by Insiders 17.45%
% Held by Institutions 138.55%
Shares Short (Mar 28, 2024) 412.24M
Short Ratio (Mar 28, 2024) 47.53
Short % of Float (Mar 28, 2024) 48.49%
Short % of Shares Outstanding (Mar 28, 2024) 48.47%
Shares Short (prior month Feb 29, 2024) 412.1M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -44.45%
Operating Margin (ttm)-52.72%

Management Effectiveness

Return on Assets (ttm)-10.52%
Return on Equity (ttm)-19.92%

Income Statement

Revenue (ttm)175.51M
Revenue Per Share (ttm)1.23
Quarterly Revenue Growth (yoy)58.60%
Gross Profit (ttm)N/A
EBITDA -74.14M
Net Income Avi to Common (ttm)-78.02M
Diluted EPS (ttm)-0.5400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)350.37M
Total Cash Per Share (mrq)2.42
Total Debt (mrq)97.61M
Total Debt/Equity (mrq)25.82%
Current Ratio (mrq)5.50
Book Value Per Share (mrq)2.63

Cash Flow Statement

Operating Cash Flow (ttm)-33.46M
Levered Free Cash Flow (ttm)-3.89M